Acadia Pharmaceuticals Inc (0A4W)
LSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current 0A4W market cap is 0. The company's latest EPS is USD -0.3733 and P/E is -45.30.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 339.08M | 441.76M | 484.15M | 517.24M | 726.44M |
| Operating Income | -246.55M | -286.59M | -170.44M | -223.6M | -73.38M |
| Net Income | -235.26M | -281.58M | -167.87M | -215.98M | -61.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 783.18M | 782.62M | 700.12M | 587.81M | 748.96M |
| Total Liabilities | 84.05M | 155.61M | 159.23M | 187.4M | 317.2M |
| Total Equity | 699.14M | 627.01M | 540.89M | 400.41M | 431.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -151.13M | -136.17M | -125.66M | -114.04M | 16.7M |
| Investing | -165.84M | 192.51M | -71.1M | 73.24M | 32M |
| Financing | 371.85M | 81M | 18.16M | 8.2M | 25.13M |
| Market Cap | 0 |
| Price to Earnings Ratio | -45.30 |
| Price to Sales Ratio | 3.82 |
| Price to Cash Ratio | 14.72 |
| Price to Book Ratio | 6.43 |
| Dividend Yield | - |
| Shares Outstanding | 164.18M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Acadia Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.acadia-pharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
